Drug Target Identified For Diabetes
New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic. Patrick Tso, PhD, professor in the UC Department of Pathology and Laboratory Medicine, has published research on the ability of apoA-IV to reduce blood sugar levels and enhance insulin secretion. The results appear the week of May 21, 2012, in the online early edition of Proceedings of the National Academy of Sciences. ApoA-IV is secreted by the small intestine in response to fat absorption... (Source: Health News from Medical News Today)

From seat belts to drug monitoring, states can cut injuries
Injuries are the leading cause of death for Americans between the ages of 1 and 44, and the third leading cause of death overall. (Source: USATODAY.com Health)